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The lack of an immunocompetent animal model for dengue mimicking the disease in humans is a
limitation for advances in this ﬁeld. Inoculation by intracerebral route of neuroadapted dengue strains in
mice is normally lethal and provides a straightforward readout parameter for vaccine testing. However,
systemic effects of infection and the immune response elicited in this model remain poorly described. In
the present work, BALB/c mice infected by the intracerebral route with neuroadapted DENV2 exhibited
several evidences of systemic involvement. DENV-inoculated mice presented virus infective particles in
the brain followed by viremia, especially in late stages of infection. Infection induced cellular and
humoral responses, with presence of activated T cells in spleen and blood, lymphocyte inﬁltration and
tissue damages in brain and liver, and an increase in serum levels of some pro-inﬂammatory cytokines.
Data highlighted an interplay between the central nervous system commitment and peripheral effects
under this experimental condition.
& 2015 Elsevier Inc. All rights reserved.Introduction
Dengue is an acute systemic viral disease that represents an
escalating public burden, nowadays considered as the most rele-
vant arthropod-borne illness. The virus, concentrated among tro-
pical and subtropical regions worldwide, is transmitted mainly by
Aedes mosquitoes, which put at risk of infection approximately
half of the world's population. It is estimated that 390 million
people are infected with dengue annually, of which 96 million
manifest the symptoms of the disease resulting in around 20
thousand deaths (Gubler, 2012; Bhatt et al., 2013). Dengue virus
(DENV) circulates as four distinct serotypes (DENV1 to 4) and
infections can be oligosymptomatic or result in a mild ﬂu-like
illness known as dengue fever (DF). Life-threatening forms of the
disease, dengue hemorrhagic fever (DHF) and dengue shock syn-
drome (DSS), occur in a minority of DF cases and exhibit mani-
festations such as plasma leakage, thrombocytopenia and hemor-
rhage, which can evolve to hypovolemic shock (Martina et al.,
2009; Chuansumrit and Chaiyaratana, 2014). In addition, compli-
cations of dengue affecting speciﬁc organs and systems, such as.the brain, peripheral nerves, liver, lung and heart, have recently
been reported (Carod-Artal et al., 2013; Póvoa et al., 2014; Ber-
kowitz et al., 2015). As there are no effective antiviral alternatives
or a vaccine available to control dengue virus infection, currently,
the countermeasures rely basically on vector control, educational
programs and symptomatic treatments.
The lack of an immunocompetent animal model that mimics all
the human clinical aspects of dengue is recognized as a key obstacle
to understand the disease immunity and also to develop a vaccine.
This fact led the scientiﬁc community to use alternative animal
approaches for dengue research, including mouse–human chimeras,
immunocompromised mice or models using non-physiological
infection routes (Yauch and Shresta, 2008). These experimental
models are very useful for investigating the mechanisms involved in
the disease, but its use for vaccine testing can have some restrictions,
since these mice may respond differently from immunocompetent
animals. An immunocompetent mouse approach in which a mouse
brain adapted virus, original from New Guinea and Hawaii dengue
outbreaks, is intracerebrally injected in animals (Sabin and Schle-
singer, 1945) has been extensively used in anti-dengue vaccine eva-
luation (Porter et al., 1998; Valdés et al., 2009; Clements et al., 2010;
Azevedo et al., 2011; Costa et al.; 2011). Nevertheless, based on
symptoms generally observed in these mice (paralysis) and the
inoculation route, this animal approach is sometimes described as
Fig. 2. Virus detection in brain samples collected from BALB/c mice infected with
DENV2. Brain samples (n¼5 to 7) extracted from mice at different days after
infection were tested for the presence of infective virus particles as measured by
indirect plaque assay in Vero cells. Virus titers are expressed by PFU count. Sta-
tistical differences were evaluated using Mann–Whitney test (npo0.05). d.a.i.-days
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nization, 2013; Plummer and Shresta, 2014). However, in humans,
even though neurological signs may be statistically underestimated
by clinical evaluations during dengue outbreaks, several forms of
central and peripheral nervous system impairments have been
described in patients with dengue (Sumarmo et al., 1978; Row et al.,
1996; Misra and Kalita, 2009). A meta-analytical study of 15 reports
considering symptoms as restlessness, irritability, dizziness, drowsi-
ness, stupor, coma or convulsion, revealed different levels of corre-
lation between these neurological signs and DSS. Strong correlations
of encephalopathy with DSS were detected in ﬁve studies from
Thailand and in a summary of other seven case-control studies (Huy
et al., 2013). Important neurological manifestations were also repor-
ted in many dengue fatal cases (Kho et al., 1981; Sumarmo et al., 1983;
Chimelli et al., 1990; Miagostovich et al., 1997), what emphasizes a
possible close connection between the central nervous system (CNS)
dysfunction and patients with severe dengue.
Despite the historical application of the intracerebrally-
inoculated immunocompetent mouse approach for anti-dengue
vaccine testing, protection was measured basically by survival/
morbidity endpoints. Little is known about other possible effects
induced after an intracerebral (i.c.) inoculation with DENV,
regarding systemic aspects and the elicited immune response. On
this purpose and based on the importance of an immunocompe-
tent environment to study DENV infection and the efﬁcacy of
vaccines, here we aimed to investigate more deeply BALB/c mice
intracerebrally inoculated with the mouse brain adapted DENV2
NGC strain. Infective virus particles were detected in the brain of
these animals as well as in the circulation, mainly in late stages of
infection. Infection induced activation of CD4þ and CD8þ T cells,
detected in spleen and blood samples. T cell inﬁltrates were also
observed in the brain and liver, which correlated with tissue
damages in these organs. In addition, humoral immune response
was elicited with activation and production of dengue speciﬁc
antibodies and animals exhibited increased serum levels of pro-
inﬂammatory cytokines. Taken together, this report brought new
aspects involving immunological features of the studied mouse
model and highlighted an interplay between the CNS commitment
and the peripheral effects under this experimental condition.after infection.
Table 1
Detection of virus in serum samples by qualitative analysis as evidenced by indirect
plaque assay in Vero cells. Values represent the number of positive animals out of a
total number of mice (between parentheses). d.a.i.-days after infection.
d.a.i.
mock 1 3 5 7 9–11
Number of animals 0(5) 1(5) 2(5) 3(5) 2(5) 5(7)Results
Morbidity and mortality of BALB/c mice intracerebrally infected with
DENV2
In the experimental mouse model using BALB/c animals
inoculated by the i.c. route with 40 LD50 of a mouse-brain adapted
DENV2 virus (NGC strain), we observed a high mortality rate
(90%), with deaths occurring from the 7th to the 15th day afterFig. 1. Susceptibility of BALB/c mice to primary DENV infection by the i.c. route. BALB
group) propagated in Vero cell cultures. Control group (Mock) is represented by animals
mice were followed up for 21 days after infection. Kaplan–Meier distributions were com
Curves were built considering only deaths, preceded or not by CNS dysfunction, such as s
death. Data represent a compilation of three independent experiments with groups ofinfection (d.a.i.) (Fig. 1A). All mock-injected mice survived the
procedure (mock and virus-infected animal groups were sig-
niﬁcantly different, po0.0001). After that, we veriﬁed the rela-
tionship between the occurrence of deaths and morbidity mani-
festation, mainly hind leg paralysis and/or alteration of spinal cord.
For this purpose, mortality curves were built considering deaths
preceded or not by symptoms related to central nervous system
(CNS) dysfunction. Morbidity were evaluated at least 16 h before
deaths and we found that a subset of DENV-infected mice (54.7%)
died after exhibiting signs of CNS dysfunction while another group
(35.3%) succumbed without exhibiting any apparent clinical signs
(Fig. 1B). In general, deaths preceded by clinical signs were broadly
distributed in time course (from 8 to 15 d.a.i.), while deaths
without morbidity were more concentrated in the early stages of
infection (from 7 to 10 d.a.i.). Therefore, data suggest that even
though there is an important component leading to death clearly
associated with CNS commitment, lethality, in several cases, is not
necessarily preceded by the observed neurologic dysfunctions./c mice were intracerebrally inoculated with 40 LD50 of DENV2 NGC strain (DENV
injected with supernatants of non-infected Vero cell cultures. (A) Survival curves-
pared using Log-Rank test using the mock group as a reference. (B) Mortality rates-
pinal cord alterations (hunchback posture) or paralysis observed at least 16 h before
6 to 7 animals in each test (n¼20). d.a.i.-days after infection.
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The presence of infective DENV2 particles was investigated by
plaque assay in Vero cell monolayers using brain, liver and serum
samples from virus-inoculated BALB/c. All animals inoculated with
DENV2 presented infective virus particles in the brain. Viral titers
were signiﬁcantly high throughout the entire evaluated period,
although a decrease was observed in days 5 and 7 (Fig. 2). As
expected, the control group (mock) showed no viral plaque formation.
Viremia was detected in animals infected with DENV2, yet in low
magnitude and not in all serum samples (Table 1). The number of
DENV2 positive serum samples gradually increased along the kinetic
study. In the ﬁrst day after infection, only one animal out of ﬁve
showed viremia, while in the last tested points (9–11 d.a.i.) we
observed ﬁve out of seven dengue positive serum samples. In order to
ensure the virus spread in i.c.-inoculated mice, DENV2–NS3 antigen
was stained by immunohistochemistry in liver samples collected from
the 9th to the 11th d.a.i. As expected, controls (liver of mock-
inoculated animals incubated with anti-NS3 antibody or the hepatic
tissue of infected mice treated only with anti-rabbit IgG conjugate)
did not present any positive reaction (Fig. 3a and b). On the other
hand, the NS3 protein was detected in hepatocytes (Fig. 3c), Kupffer
cells (Fig. 3d) and endothelial cells (Fig. 3e). The detection of NS3 not
only endorsed the DENV spread in this murine model but also
revealed virus replication in the liver. Therefore, in this murine model,
the brain seemed to be the main organ for virus replication, although
infection led to the spread of infective virus particles to the circulation
reaching also a peripheral organ.
Activated T cells in spleen and blood
The levels of T cell populations and the presence of activated
subpopulations were investigated in spleen and blood samples of
DENV2-infected BALB/c mice. The ﬂow cytometry gate strategyFig. 3. Detection of NS3 protein in liver samples of BALB/c mice infected with DENV2. BA
were processed for NS3 immunohistochemical staining. Liver of a mock-inoculated mou
DENV2-infected mouse incubated only with anti-rabbit IgG conjugate (b); Liver tissue
Kupffer cells (d) and endothelial cells (e). Hepatocytes (H); Kupffer cells (KC); endotheli
Harris hematoxylin. Image of infected mice is representative of positive animals foundapplied for this analysis is described in Fig. 4. No differences were
detected on the percentages of TCD4þ cells analyzed in splenocytes
collected at all time points (1, 3, 5, 7 and 9–11 d.a.i.) when compared
to non-infected controls (Fig. 5 top). Regarding the TCD8þ subset, a
percentage increase of this population was observed at the 5th d.a.i.
and this effect remained throughout the rest of the experiment. We
considered as a T cell activation marker the expression of CD45RBlow
on the cell surface. In this context, we found that percentages of both
TCD4þCD45RBlow and TCD8þCD45RBlow splenocytes increased after
DENV infection (Fig. 5 top). At the 3rd d.a.i., approximately 50% of
TCD4þ cells were CD45RBlow, whereas the activated TCD8þ sub-
population, signiﬁcantly detected only at the 5th d.a.i., represented
about 20% of the TCD8þ subset. When the same analysis was per-
formed in blood samples, we observed a similar pattern. Percentages
of TCD4þ cells did not vary during the investigated period, while
TCD8þ subset was higher in day 5 when compared to non-infected
samples (Fig. 5 bottom left). Concerning activated T lymphocytes,
percentages of TCD4þCD45RBlow cells increased from day 3 onwards
reaching a peak level at the 7th d.a.i. (about 40% of the TCD4þ),
whereas the percentage of TCD8þCD45RBlow only increased sig-
niﬁcantly at the 5th d.a.i. (25% of the TCD8þ) (Fig. 5 bottom left).
Levels of activated T cell subpopulations also increased signiﬁcantly
when analyzed by absolute counts (Fig. 5 bottom right). Negative
control was performed using blood and spleen samples of mock-
infected mice, measured at the 5th d.a.i., and no differences were
found when compared to non-infected animals (day 0, data not
shown). Taken together, results indicated that DENV infection by the
i.c. route led to T cell activation.
T cell inﬁltrates and histopathological aspects of the brain of infected
mice
Since the main clinical manifestations in this mouse model are
related to CNS commitment, the presence of T cell inﬁltrates wereLB/c mice were i.c.-inoculated with DENV2 NGC strain, sacriﬁced 10 d.a.i., and livers
se incubated with anti-NS3 antibody and anti- rabbit IgG conjugate (a); Liver of a
from an infected animal showing the detection of NS3 antigen in hepatocytes (c),
al cells (EC). Arrows indicate positive reactions. Sections were counter stained with
in viremia assay (Table 1, group 9–11 d.a.i.).
Fig. 4. Gate strategy for analysis of T cell activation in blood and spleen samples. (A) Ungated forward and side light scatter (FSC SSC) dot plot exhibiting a region
considered as the lymphocyte region. (B and C) Histograms showing the expression of CD4 and CD8 in the CD3þ lymphocytes. (D and E) Histograms of representative blood
samples (non-infected or 5 d.a.i.) exhibiting CD45RBlow events (considered as activated T cells) measured in CD3þCD8þ or CD3þCD4þ counts. Values indicate percentages of
cells. d.a.i.-days after infection.
Fig. 5. T cell activation in spleen and blood of DENV-infected mice. The activation of T cells in mice infected with the mouse-brain adapted virus was studied based on the
modulation of the expression of CD45RB on the lymphocyte surface. Spleen (top) and blood (bottom) samples were collected from BALB/c mice in different time points after
infection with DENV2 and analyzed by ﬂow cytometry. Activated cells (CD45RBlow) were measured in CD3þCD4þ or in CD3þCD8þ events, all gated in lymphocyte con-
ventional region. Values represent percentages with median and interquartile range (top and bottom left). Absolute counts (bottom right) of T cells and activated sub-
populations present in blood samples were measured in the time course of infection. Statistical differences between non-infected and infected groups were evaluated using
Mann–Whitney test (npo0.05; nnpo0.01). Data represent a compilation of three independent experiments with groups of 5 animals in each test (total n¼15). d.a.i.-days
after infection.
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Fig. 6. Lymphocyte inﬁltrates into the brain of infected mice. (A) Original ﬂow cytometry dot plots showing FSC SSC of cells isolated from the brain of animals on days
3 and 9–11 after infection. An additional control consisted of a brain of non-infected mice, which was processed in the presence of a small portion of splenocytes obtained
from the same animal (spiked sample), was performed in order to set the lymphocyte region for further analysis. (B) Percentages of lymphocytes present in samples of mock,
3 and 9–11 d.a.i. Histograms show the presence of CD4þ and CD8þ cells in the brain inﬁltrates. Statistical differences between mock and infected groups were evaluated
using Mann–Whitney test (*po0.05). Data represent a compilation of two independent experiments with groups of 5 animals in each test (total n¼10). d.a.i.-days after
infection.
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animals on days 9 to 11 after infection with DENV2 (all of them
showing clinical signs) were elected for this analysis and com-
pared with early-infected (3rd d.a.i) and mock-infected mice. To
ensure the feasibility of lymphocyte detection from brain samples
by ﬂow cytometry analysis, additional controls were made
(“spiked sample”), in which brains from non-infected animals
were macerated together with a small quantity of splenocytes
obtained from the same animals. As indicated in Fig. 6A, spleno-
cytes were successfully recovered from the spiked sample, thus
conﬁrming the usefulness of the applied protocol. After infection, a
T cell population, including CD4þ and CD8þ , was detected only in
samples obtained at 9–11 days (Fig. 6A and B). In accordance to
this observation, lymphocyte inﬁltrates were also seen in brain
tissues of animals at the 10th d.a.i., as determined by histological
analysis. In brain cuts, we observed diffuse mononuclear cell
inﬁltrates in pia mater and molecular layer, as well as perivascular
leukocyte cell migration inside interstitial temporal cortex (Fig. 7b
and c). Interstitial hemorrhage was an additional alteration
detected in brain tissues of infected mice (Fig. 7d). All together,
both analyses showed that, in the present mouse model, severe
symptomatic manifestations and T cell inﬁltrates in the brain occur
simultaneously and may be somehow related.
T cell inﬁltrates detected in the liver and the commitment of this
organ during infection
Besides studies concerning T cell inﬁltrates in the brain of
infected mice, we also investigated the presence of lymphocyteinﬁltrates in the liver of these animals. Although mice were virus
challenged by the i.c. route, the liver was evaluated since this
organ is considered as an important target in dengue disease. Flow
cytometry analysis was carried out according to Fig. 8. A signiﬁcant
increase on the percentages of TCD8þ lymphocytes was detected
in animals at 9–11th d.a.i., when compared to non-infected
controls, while no differences on the percentages of TCD4þ
population were detected (Fig. 9 top). On the other hand, once
considering activated (CD45RBlow) and effector (CD44hiCD62L)
subpopulations, we observed an increase in both CD4þ and CD8þ
cells during the same period when compared to controls. The
percentage of the TCD8þCD44hiCD62L subpopulation was
already increased at the 3rd d.a.i. (Fig. 9 bottom). These data were
supported by histological ﬁndings, in which hepatic tissues of
infected animals presented lymphocyte inﬁltrates either around
the portal space or distributed in parenchyma, mainly in late
stages of infection (Fig. 10d and e). Microsteatosis, necrosis and
circulatory dysfunctions, such as hemorrhage and edema, were
also characterized in interstitial parenchyma since the beginning
of infection (one day after virus inoculation) (Fig. 10b and c). As
expected, in control mice (mock-infected) the hepatic tissue
exhibited regular and preserved structures (Fig. 10a). Consistent
with histopathological observations, serum levels of AST sig-
niﬁcantly increased in mice after 9–11 d.a.i. (Fig. 11). After all, these
data indicated that the liver was affected in the present mouse
model, thus conﬁrming that the virus infection by the i.c. route can
evolve to a systemic commitment.
Fig. 7. Histopathological aspects of the brain tissue of BALB/c mice infected with DENV2. (a) A representative mouse inoculated with mock, revealing normal aspects of the
cerebral cortex. (b) Animals infected with DENV2 showing mononuclear cell inﬁltrates (large black arrows) in pia mater and molecular layer. Commitment with perivascular
leukocyte cell migration inside interstitial temporal cortex (c), and hemorrhage in the cerebral parenchyma (d), observed 10 days after infection. BV-Blood vessels; He-
hemorrhage; PM-pia mater; ML-molecular layer, GL- granular layer, PL – piramidal layer. Tissue sections were stained with hematoxylin/eosin and visualized by optical
microscopy.
Fig. 8. Gate strategy for analysis of T cell activation in liver samples. Lymphocytes were isolated from liver by density gradient and analyzed by ﬂow cytometry to investigate
the presence of activated/effector T cells. (A) Ungated FSC SSC ﬂow cytometry dot plot exhibiting a region considered as the lymphocyte region. (B) Cytometric dot plot
showing the CD4þ and CD8þ cells measured in the lymphocyte region. (C and D) Histograms and contour representations containing the considered regions of activated
(CD45RBlow) or effector (CD44hiCD62L) T cells measured in CD8þ or CD4þ counts isolated from an infected animal 10 days after infection.
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In order to investigate the participation of the host humoral
immune response during infection, we ﬁrst analyzed the expres-
sion of IgD in the surface of B220þ cells using ﬂow cytometry.
Populations of higher (B220þhg) or lower (B220þlg ) internal com-
plexity, as determined by side scatter parameter (SSC), were ana-
lyzed separately since this phenotypic parameter can reﬂect an
increase of synthesis and activation of cells (Fig. 12A). In this
approach, we measured the down regulation of IgD on the surface
of these cells, as an evidence of B cell differentiation. We observed,in blood and spleen samples, that DENV infection led to an
increase of B220þhgIgD cell percentages in late stages of the
kinetic study (9–11 d.a.i.), when compared to controls (Fig. 12B and
C). No differences were observed considering the B220þlg IgD
percentages between mock and infected groups (data not shown).
ELISA assays using DENV2 NS1 as a solid-phase antigen were
additionally performed in order to investigate the antibody
secreting cell response against this virus protein. Consistent with
the ﬂow cytometry experiments described above, anti-NS1 IgM
antibodies were detected at the 5th d.a.i., reaching titers of 1/200
in the ﬁnal points of the study (9–11th d.a.i.). Anti-NS1 IgG
Fig. 9. Effector T cell response in the liver of infected mice. Effector T cell response was evaluated in the liver of BALB/c mice (n¼5 per group) inoculated with DENV2 by the i.
c. route in different days after infection. Flow cytometry analysis of samples isolated from the hepatic tissue, regarding T cell populations measured in the lymphocyte region
(top: CD4þ and CD8þ), and activated/effector T cell subpopulations measured in CD4þ or CD8þ events (bottom: CD45RBlow and CD44hiCD62L). Statistical differences
between non-infected and infected groups were evaluated using Mann–Whitney test (npo0.05; nnpo0.01). Data represent a compilation of three independent experiments
with groups of 5 animals in each test (total n¼15). d.a.i.-days after infection.
Fig. 10. Histopathological aspects of the liver tissue in BALB/c mice infected with DENV2. (a) A representative mouse inoculated with mock, revealing normal aspect of the
hepatic parenchyma. (b–c) Animals infected with DENV2 exhibiting tissue damages, mainly edema, hemorrhage (b), necrosis and microesteatose (c) were already found in
the beginning of infection (at the 1st and 5th d.a.i., respectively). Mononuclear inﬁltrates around the portal space (d) and distributed in the liver parenchyma (e) were
observed 10 days post infection. CV-central vein; PV-portal vein; BD- biliar duct; E-edema; He-hemorrhage; Ne – necrosis; arrowhead indicate microesteatose; large black
arrows indicate inﬁltrates. The tissue sections were stained with hematoxylin/eosin and visualized under optical microscopy.
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titers of approximately 1/700 (Fig. 12D). Thus, results indicated the
participation of the humoral immunity in response to DENV
infection by the i.c. route, with activation of B lymphocytes and
production of antibodies.Pro-inﬂammatory cytokines present in blood of infected BALB/c mice
After showing the participation of T and B cell response elicited
by the i.c. infection, the quantiﬁcation of pro-inﬂammatory cyto-
kines in blood was our next step to characterize this mouse model.
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tested for IL-12p70, TNF-α, IFN-γ, MCP-1, IL-10 and IL-6 by cyto-
metric bead array (CBA) technique. Following 24 h of virus chal-
lenge, levels of IL-12p70, TNF-α and MCP-1 signiﬁcantly increased
when compared to non-infected controls. Levels of all these
cytokines dropped below limits of detection in the next evaluatedFig. 11. Serum levels of liver enzymes in infected mice. The enzymes alanine
aminotransferase (ALT) and aspartate aminotransferase (AST) were quantiﬁed by
dry biochemistry at different days after infection (n ranging from 5 to 13). Statistical
differences between non-infected and infected groups were evaluated using Mann–
Whitney test (nnpo0.01). d.a.i.-days after infection.
Fig. 12. Humoral immune response in infected BALB/c mice. B cell response was evalua
period of 9–11 days after infection. (A) Flow cytometry strategy representing B220þ cells
of high (hg) or low (lg) granulosity and the expression of IgD was measured in the cell s
quantitative analysis of IgD cells gated in B220þhg events present in spleen or blood sam
infected and infected groups were evaluated using Mann–Whitney test (npo0.05; nnpo
different d.a.i. Values are expressed as mean and standard deviation. Data represent a c
(total n¼10). d.a.i.-days after infection. #undetectable value.days, but IL-12p70 and TNF-α increased again at the 7th d.a.i.
(Fig. 13). Although levels of IL-10 and IL-6 were mostly beneath the
detection limits, IL-10 showed a behavior similar to IL-12p70 and
TNF-α, exhibiting peaks at days 1 and 7 after infection. Regarding
IFN-γ, a signiﬁcant peak was detected at the 7th d.a.i. Additional
cytokine determinations were also performed in an attempt to
correlate the serum levels with clinical manifestations in mice.
Since the 7th day was the initial point where symptoms appeared,
serum samples from 7–11 d.a.i. were analyzed and groups were
divided as “with” or “without” clinical manifestations. Despite this
effort, no statistical difference in cytokine levels was found
between these studied groups (Fig S1). In a brief conclusion, the
cytokine proﬁles suggested activation of innate mechanism at the
beginning of infection, followed by an induction of the adaptive
immunity, as seen by the INF-γ increase at late stages of the study.Discussion
The application of a neuroadapted dengue strain to generate a
lethal infection after intracerebral inoculation in mice has been
used since Sabin and Schlesinger (1945) and provides a very
straightforward readout parameter for vaccine testing. The pro-
tective potential of a proposed vaccine or antiviral can be directly
assessed by its capability or not to prevent morbidity andted in blood samples of BALB/c mice intracerebrally inoculated with DENV2 in the
analyzed in the lymphocyte region. The B220þ lymphocytes were divided in events
urface. (B) Cytometric hystograms showing the expression proﬁle of IgD and (C) the
ples of mice. Values represent percentages and statistical differences between non-
0.01). (D) Titer of anti-NS1 IgM and IgG measured by ELISA in plasma of mice at
ompilation of two independent experiments with groups of 5 animals in each test
Fig. 13. Plasma levels of proinﬂammatory cytokines of infected mice. Plasma samples of BALB/c mice inoculated with DENV2 by the intracerebral route (n ranging from 4 to
10) were collected in different days post-infection and quantiﬁed for IL-12p70, TNF-α, IFN-γ, MCP-1, IL-10 and IL-6, using cytometric bead array technique. Values are plotted
individually with median for each group. Statistical differences between non-infected and infected groups were evaluated using Mann–Whitney test (npo0.05; nnpo0.01).
Dotted line represents the limit of detection for each cytokine deﬁned by the manufacturer. d.a.i.-days after infection.
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about the systemic effects and the immune mechanisms involved
during the virus infection. The present work was conducted in
regards to better understand this mouse model. Under our
experimental conditions, in which BALB/c mice received DENV2
NGC by the i.c. route, we found that usually at the 7th day of
infection mice started to exhibit paralysis and hunchback posture,
which are apparently the main symptoms within infected groups.
After the appearance of this condition, the clinical signs generally
evolved to death. Curiously, we observed that a fraction of infected
mice succumbed to the infection differently, without showing any
apparent CNS commitment. We hypothesized that distinct
mechanisms of pathology and immunity, yet to be investigated,
may lie behind such differences in morbidity in this inbred and
isogenically-based animal model.
The ﬁrst general discussion in this work is concerned on the
typical clinical signs observed among infected mice. It is com-
monly discussed in the literature that the neurovirulence induced
after DENV infection in mice would represent a major caveat in the
determination of an appropriate model to study the disease (Yauch
and Shresta, 2008; Sarathy et al., 2015). In fact, some authors
defend that the involvement of CNS in DENV infections is notrelevant in humans due to its rare occurrence (Patey et al., 1993;
Lum et al., 1996). However, other reports showed that the CNS
involvement with dengue actually is not so uncommon. From 150
fatal cases in Brazil (due to suspected infectious disease), 84
patients presented DENV in serum and 41 had the virus isolated
from the cerebral spinal ﬂuid (CSF) (Araújo et al., 2012). Studies in
India also reported a relevant incidence of neurologic complica-
tions (2.6%) in infected patients (Koshy et al., 2012) and seizures
(24%) in individuals with dengue encephalitis (Misra and Kalita,
2009). Although diagnostic criteria for dengue encephalitis have
been proposed, they are controversial because detection of either
viral RNA or speciﬁc IgM antibodies in the CSF may be disease-
course dependent (Carod-Artal et al., 2013; Soares and Puccioni-
Sohler, 2013). In consequence, this can eventually result in a wrong
perception of the CNS involvement with dengue. In mouse models
for dengue disease, paralysis is also observed even when using
non-intracerebral infection routes or non-neuroadapted virus
strains. For example, A/J mice, engrafted SCID mice and AG129
mice can exhibit paralysis after infection with DENV, in the last
case after TNF-α inhibition (Lin et al., 1998; Shresta et al., 2004;
Zellweger et al., 2013; Plummer and Shresta, 2014). Based on these
observations, we may consider that the neuroadaptation of DENV
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immunocompetent mice, but the neurotropism of DENV in these
animals seems to be a natural characteristic of this virus.
Initially, to investigate the intracerebrally infected animals, we
measured the presence of infective virus particles in the brain and
bloodstream. As expected, considerable amounts of virus were
found in brain tissues collected in all time points (1 to 9–11 d.a.i.).
Interestingly, the number of virus particles signiﬁcantly decreased
at the 5th d.a.i., after which it gradually increased until the end of
the evaluation (9–11 d.a.i.). In addition to that, T cell inﬁltrates were
found in the CNS (characterized by ﬂow cytometry and histological
analysis) of animals in late stages of infection (9–11 d.a.i.). Apart
from other potential protective mechanisms in the CNS, the corre-
lation between the increased virus titers in the brain in late stages
of infection and the presence of T cell inﬁltrates in this organ sug-
gested an ongoing peripheral cellular immune response. These
results may contradict traditional theories, because the CNS is
considered an immune-privileged tissue protected by a speciﬁc
vessel structure, the blood–brain barrier (BBB), which in turn
should block the migration of lymphocytes into this area. However,
studies already demonstrated that upon infection or traumatic
injury in the CNS, various immune cells are recruited to the affected
space, trespassing the BBB (Arima et al., 2012; Kamimura et al.,
2013). It is important to note that mock-inoculated animals, which
also had the traumatic injury of injection, did not show tissue
damages or cell inﬁltrates as observed in the brain of infected
animals, thus reinforcing the direct effect of virus infection.
The spread of infective virus particles to the circulation in this
animal model, although in a low magnitude, was also an important
ﬁnding which can explain the systemic effects that we have
observed. Consistent to this, T cell inﬁltrates and activated/effector T
cell phenotypes in liver tissues of infected mice were also found.
Taken together, these results suggested that the virus present in the
circulation could affect peripheral organs. Other studies have also
shown that the liver is an important target organ during DENV
infection in mice. C57BL/6 mice infected intravenously (Sung et al.,
2012) and BALB/c mice that received the virus by the subcutaneous
(França et al., 2010), intraperitoneal (Paes et al., 2005) or intrave-
nous (Paes et al. 2009) routes presented hepatic alterations. The
major hepatic alterations observed in our study were steatosis,
necrosis, areas of hemorrhage and edema/plasma leakage, which
are similar to the effects described in fatal human cases
(Bhamarapravati et al., 1967; Burke, 1968; Couvelard et al., 1999;
Huerre et al., 2001; Basílio-de-Oliveira et al., 2005; Martina et al.,
2009; Póvoa et al., 2014) as well as in other mouse models (Paes et
al., 2005, 2009). Moreover, a signiﬁcant increase of AST levels was
detected in serum of infected mice at late stages of infection. In
congruence to these ﬁndings, it was also reported that an increase
of this liver enzyme occurs both in humans and mice due to dengue
infection (Nguyen et al., 1997, Souza et al., 2004, Paes et al., 2005,
2009). Still considering our studied mouse model, diffuse mono-
nuclear cell inﬁltrates in pia mater and in the molecular layer was
found in the brain of infected mice. Perivascular leukocyte cell
migration was also characterized in the temporal cortex. Similar
ﬁndings were also seen in other reports of mouse models for
dengue disease concerning different serotypes (Bordignon et al.,
2008, Velandia-Romero et al., 2012, de Souza et al., 2013).
After the intracerebral infection of BALB/c mice, apart from the
effects described above, we also found activated T cells in spleen
and blood of these animals as well as humoral and cytokine
responses. The participation of these responses is well docu-
mented in dengue cases (Rothman, 2011). One assumption that
would explain the systemic involvement after the i.c.-infection, is
that during inoculation, the mechanic damage would also result in
virus spread to the circulation. This way, virus particles would
infect other locations and antigens could reach lymphoid organs.Another possible explanation would be the commitment of the
BBB due to the establishment of virus infection in the brain leading
to virus spread. A third supposition to analyze this scenario
involves a physiological communication between the CNS envir-
onment and the periphery. Classically, we understand that the
relative immune privilege of the CNS is based upon a lack of access
of cells and antigens from the brain to secondary lymphoid organs
(Engelhardt and Coisne, 2011). Even though no classical lymph
vessels are present in the CNS, several exit routes of the brain for
cells and antigens are now well established (Weller et al., 2010;
Laman and Weller, 2012). According to reports in the literature, it
seems that due to an efﬁcient drainage of both cerebrospinal ﬂuid
and interstitial ﬂuid from the CNS, antigen presenting cells (APCs)
and antigens existing in the brain tissue would reach regional
lymphoid organs (Laman and Weller, 2012). It was found, for
example, that in healthy animals dendritic cells injected into the
CSF, migrate to cervical lymph nodes and may also build the
connection to the humoral response, since these cells preferably
migrate to B-cell regions in the lymphoid tissue (Hatterer et al.,
2006). Thus, in the present mouse model, we speculate that a
possible escape of APCs though speciﬁc exit routes present in the
CNS would represent an important link between the i.c.-infection
and the systemic effects observed. Yet, more investigation is still
necessary in order to ensure the participation of these mechan-
isms in this model.
Taken together one important advantage of this murine model
is the possibility to evaluate immune mechanisms elicited from an
immunocompetent organism after challenge with DENV. Since no
appropriate mouse model for dengue is yet available, the present
work aimed to better understand the environment, effects and
limitations of this still poorly described model that has been
extensively used among the scientiﬁc community. Under our
experimental conditions, infection in these animals led to systemic
effects. Although the correlation of these systemic ﬁndings to the
disease in humans has limitations due to the infection route and
the used dengue virus variant, our data wide the knowledge about
such model and highlights an interplay between the CNS com-
mitment and peripheral effects.Conclusions
In this work, we found that immunocompetent BALB/c mice
inoculated by the i.c. route with a neuroadapted DENV strain can
display peripheral effects such as cellular and humoral responses.
These effects included: T cell activation and migration to affected
organs, antibody production against virus proteins, and pro-
inﬂammatory cytokine production. Besides lethality, these para-
meters may represent new endpoints to evaluate anti-dengue
vaccines and/or antiviral substances. Even though the relevance of
this murine model to describe dengue pathogenesis in humans
may be restricted, this work provides a better understanding of
such approach.Materials and methods
Mice infection
The mouse–brain adapted dengue 2 virus (DENV2), strain
New Guinea C (NGC) (GenBank M29095), was used for animal
infections. DENV2 NGC strain propagation was carried out in Vero
cells cultured in medium 199 with Earle salts (E199) buffered with
sodium bicarbonate (Sigma, USA), supplemented with 10% fetal
bovine serum (FBS, Invitrogen, USA). Supernatants obtained from
cell cultures without virus were used for mock inoculations.
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ethical principles in animal experimentation stated in the Brazilian
College of Animal Experimentation and approved by the Institute's
Animal Use Ethical Committee (approval ID: L067/08 and LW14/12).
Male BALB/c mice, speciﬁc pathogen free (SPF), 4 to 6 weeks
old, were anesthetized with a mixture of ketamine–xylazine
(Erhardt et al., 1984) and intracerebrally inoculated with 30 mL of
DENV2 NGC 40 LD50, diluted in E199 medium. For recording
mortality rates, groups of animals were followed up for 21 days
post infection and after that period they were sacriﬁced. Morbidity
signs were count as the appearance of hind leg paralysis and
alterations in spinal column. Infected or control animals were also
sacriﬁced at different time points for kinetic studies, and blood,
obtained from cardiac puncture, spleens, livers and brains were
collected for further analysis.
Virus detection
Brain, liver and serum samples were obtained from animals
inoculated with DENV2, or with mock control, at days 1, 3, 5, 7, and
9–11 after infection and stored in liquid nitrogen. DENV2 detection
was performed in Vero cell monolayers grown in 24-well plates
with medium E199, 1% garamycin, buffered with 5% sodium
bicarbonate, supplemented with 5% FBS, and maintained at 37 °C
in 5% CO2. In the next day, brain or liver samples, macerated in
E199 medium, as well as serum, were serially diluted (from 101 to
106) and added to cell monolayers, followed by incubation for 1 h
at 37 °C in 5% CO2. Culture medium was then removed and cells
were maintained for 6 days with 1 ml of semi-solid E199 medium
(with 3% carboxymethylcellulose, 1% garamycin, buffered with 5%
sodium bicarbonate, supplemented with 5% FBS) also at 37 °C in
5% CO2. After this period, cells were ﬁxed with 10% formalin,
stained with crystal violet and plaques were manually counted.
When detection of DENV2 was in high magnitude, viral titers were
calculated and expressed as the sample dilution which lead to the
presence of 50% of plaque forming units (PFU)/mL and values were
plotted as log10.
Immunohistochemistry assay
For immunohistochemistry assay parafﬁn-embedded liver tis-
sues were cut (4 mm), deparafﬁnized in xylene and rehydrated
with alcohol. Antigen retrieval was performed by heating the tis-
sue in the presence of citrate buffer (Shi et al., 2011). The liver of
mice were then blocked for endogenous peroxidase with 3%
hydrogen peroxidase in methanol and rinsed in Tris–HCl (pH 7.4).
Then, liver sections were incubated with Protein Blocker solution
(Spring Biosciense) for 5 min at room temperature to reduce non-
speciﬁc binding. Afterwards, samples were incubated over-night at
40 °C with anti-NS3 speciﬁc antibody (1:100) that recognizes
recombinant dengue NS3 protein (expressed in Escherichia coli
puriﬁed and produced in rabbit). In the next day, sections were
incubated with anti-rabbit IgG, as secondary antibody-HRP con-
jugate (Spring Bioscience, CA, USA), for 30 min at room tempera-
ture. Mock-inoculated mice sections were used to control the
reaction. Samples were revealed with diaminobenzidine (Dako,
CA, USA) as a chromogen, sections were counter stained in Meyer's
hematoxylin (Dako) and observed under an optical microscope.
Flow cytometry
For ﬂow cytometry analysis, leukocytes were isolated from blood,
spleen, brain and liver. All organs were dissociated in wire mesh
screens using RPMI medium. Spleen macerates and blood samples
were treated with BD FACS Lysing for red blood cell lysis and ﬁxation
according to manufacturer's instructions (BD Biosciences, USA).Brain inﬁltrated leukocytes were isolated by Percoll and Ficoll gra-
dients. For the Percoll gradient, 5 mL of brain macerates were added
to a tube containing 10 mL of RPMI, 9 mL of Percoll and 1 mL of PBS
10x. Samples were centrifuged at 7800 g for 30 min at room tem-
perature. Leukocyte rings obtained after separation were washed
and suspended in 5 mL of RPMI. Isolates were then gently trans-
ferred to tubes containing 5 mL of Ficoll. Samples were spinned
down at 800 g for 30 min at room temperature. Mononuclear cell
ring and interphase were isolated, washed two times and suspended
in PBS pH 7.4. Samples were then treated with BD FACS Lysing
solution. Leukocyte puriﬁcation from liver macerates was carried out
using only the Ficoll density gradient followed by treatment with BD
FACS Lysing, as described above.
Isolated cells were ﬁnally washed and suspended in PBS/BSA
1%. Approximately 106 cells were stained on ice for 20 min in the
dark with the following mab combinations: (i) B220-APC, IgD-FITC
and CD4-PE; (ii) CD3-PE, CD4-Alexa Fluor 647, CD8-PercP and
CD45RB-FITC or (iii) CD4-Alexa Fluor 647, CD8-PercP, CD45RB-
FITC, CD44-PE and CD62L-PECy7. All mabs used for this work were
obtained from BD Biosciences and background-staining controls
were performed using isotypes recommended by the manu-
facturer. Samples were read in a BD FACS Canto II and analyzed
ofﬂine with FlowJo (Three StarInc, USA) software.Histological analysis
Brain and liver tissue samples from BALB/c mice inoculated
with DENV2 NGC or mock were fragmented, ﬁxed in formalin
(10%) and blocked in parafﬁn resin. Sections were cut with 4 mm of
thickness, deparaﬁnized in xylene and rehydrated with alcohol, as
previously described (Paes et al., 2009). Tissue sections were then
stained with hematoxylin and eosin for histological examination
and visualized under a Nikon ECLIPSE E600 microscope.Hepatic enzyme quantiﬁcation
BALB/c mice were bled on days 0, 1, 3, 5, 7 and 9–11 after virus
inoculation and serum samples were stored at 70 °C until use.
Levels of alanine aminotransferase (ALT) and aspartate amino-
transferase (AST) were measured (U/L) by the biochemical analy-
zer Reﬂotrons Plus (Roche, Switzerland) as determined by the
manufacturer.Detection of anti-NS1 antibody response
Plasma samples were tested individually for the presence of
NS1-speciﬁc antibodies by ELISA. Brieﬂy, MaxiSorp plates (Nunc,
Denmark) were coated with 0.4 mg/well of refolded recombinant
NS1 protein (Amorim et al., 2010) in PBS, and incubated for 1 h at
37 °C. After this period, wells were overnight-blocked with 2%
skim milk in 0.05% Tween-20-PBS (PBST). In the next day, serum
samples were serially diluted and added to plates previously
washed 5 times with PBST. After 1 h at 37 °C, plates were washed
again with PBST and incubated with goat anti-mouse IgG or IgM,
both conjugated with horseradish peroxidase (Southern Bio-
technology, USA) for 1 h at 37 °C. Plates were washed in PBST and
incubated with ortho-phenylenediamine dihydrochloride (Sigma,
USA) and H2O2 for 20 min at room temperature. Reaction was
stopped with 9 N H2SO4 solution and visualized at A 490 nm.
Titers were established as the reciprocal of serum dilution that
gave absorbance higher than mean values of respective non-
infected mouse samples.
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Cytokines were measured with BD CBA Mouse inﬂammation kit
(BD Bioscience) using plasma of infected animals. In this analysis,
interleukin-12p70 (IL-12p70), interleukin-6 (IL-6), interferon-γ
(IFN-γ), tumor necrosis factor-α (TNF-α), interleukin-10 (IL-10)
and monocyte chemotactic protein 1 (MCP-1) were simulta-
neously detected in each sample. Detection was performed
according to the manufacturer's instruction with modiﬁcations.
Brieﬂy, beads coated with six speciﬁc capture antibodies were
pooled. Subsequently, 25 μL of the mixed captured beads, 25 μL of
the tested plasma sample or the provided standard cytokines and
25 μL of PE-detection reagent were added consecutively to each
assay tube, incubated for 2 h at room temperature in the dark.
Samples were washed and centrifuged at 200 g for 5 min. Super-
natants were discharged and the bead pellets were suspended in
300 μL of a buffer provided by the manufacturer. Samples were
read on a BD FACS Canto II Flow Cytometer and analyzed by FCAP
ArrayTM Software (BD Bioscience). Cytokine standards were seri-
ally diluted for the construction of calibration curves to assess
cytokine concentrations in tested samples. The theoretical limits of
detection were 10.7 pg/mL for IL-12p70, 5.0 pg/mL for IL-6,
2.5 pg/mL for IFN-γ, 7.3 pg/mL for TNF, 17.5 pg/mL for IL-10 and
52.7 pg/mL for MCP-1.
Statistical analysis
Data were analyzed with GraphPad prism software v 5.1 (La Jolla,
USA) using non-parametric tests. Mann–Whitney test was applied
for comparisons in ELISA or ﬂow cytometry tests. Kaplan–Meyer
survival distributions were evaluated using Log-Rank statistical test
to check differences on biological treatments. Relevant differences
were deﬁned with probability (p) values inferior to 0.05.Acknowledgments
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